Clinical Trials
Clinical Trials Links
Arcutis is acting with urgency to deliver therapies that bring meaningful benefits to millions of patients who are burdened by serious diseases of the skin. Learn more about our clinical trials.
Topical Roflumilast Cream (ARQ-151) Phase 3 in Atopic Dermatitis (INTEGUMENT-1)
Topical Roflumilast Cream (ARQ-151) Phase 3 in Atopic Dermatitis (INTEGUMENT-2)
Topical Roflumilast Cream (ARQ-151) Phase 3 in Plaque Psoriasis (DERMIS-1)
Topical Roflumilast Cream (ARQ-151) Phase 3 in Plaque Psoriasis (DERMIS-2)
Topical Roflumilast Cream (ARQ-151) Phase 3 Plaque Psoriasis Open Label Extension (DERMIS-OLE)
Topical Roflumilast Cream (ARQ-151) Phase 2a in Plaque Psoriasis
Topical Roflumilast Cream (ARQ-151) Phase 2a open label extension in Plaque Psoriasis
Topical Roflumilast Cream (ARQ-151) Phase 2b in Plaque Psoriasis
Topical Rolfumilast Cream (ARQ-151) Phase 2 in Atopic Dermatitis
Topical Roflumilast Foam (ARQ-154) Phase 2 POC in Sebhorreic Dermatitis
Topical Roflumilast Foam (ARQ-154) long-term safety study in Sebhorreic Dermatitis
Topical Roflumilast Foam (ARQ-154) Phase 2b in Scalp Psoriasis